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Incidence of cancer among UK Gulf war veterans: cohort study
Gary J Macfarlane, Anne-Marie Biggs, Noreen Maconochie, Matthew Hotopf, Patricia Doyle, Mark Lunt
Abstract
Objectives To determine whether incidence rates of cancer are
higher in UK service personnel who were deployed in the Gulf
war than in those not deployed and whether any increased risk
of cancer is related to self reported exposures to potentially
hazardous material during the period of deployment.
Design A cohort study with follow up from 1 April 1991 (the
end of the Gulf war) to 31 July 2002.
Participants 51 721 Gulf war veterans and 50 755 service
personnel matched for age, sex, rank, service, and level of fitness
who were not deployed in the Gulf (the Era cohort).
Main outcome measures Incident cancers, identified on the
NHS central register.
Results There were 270 incident cancers among the Gulf
cohort and 269 among the Era cohort (incidence rate ratio
0.99, 95% confidence interval 0.83 to 1.17). There was no excess
in site specific cancers among the Gulf cohort. Adjustment for
lifestyle factors (smoking and alcohol consumption) did not
alter these results. In the Gulf cohort, risk of cancer was not
related to multiple vaccinations or exposure to pesticides or
depleted uranium during deployment.
Conclusion There is no current excess risk of cancer overall
nor of site specific cancers in Gulf war veterans. Specific
exposures during deployment have not resulted in a
subsequent increased risk of cancer. The long latent period for
cancer, however, necessitates the continued follow up of these
cohorts.
Introduction
Studies among UK veterans of the Gulf war have shown an
excess of self reported morbidity compared with that seen in
members of the armed forces who were serving at the time of the
Gulf war (1991) and were fit for active service but were not
deployed.1 2 The excess is evident across all types of morbidity,
but there are no unusual clusters of symptoms.2 3 The symptoms
most commonly reported are non-specific, such as fatigue,
stiffness, sleep disturbance, sudden changes of mood, irritability,
and poor memory.
There has been concern about a possible link between serv-
ice in the Gulf and an increased risk of cancer, particularly in
relation to personnel who were exposed to depleted uranium. A
review of the evidence, however, concluded that, except in
extreme circumstances, any excess risk is likely to be small.4 A US
study among a sample of Gulf war veterans found an excess of
testicular cancer in the short term,5 while a study of admissions
to hospital among US Gulf War veterans found excess
admissions for cancers (mostly benign) during 1991. Mortality
studies of US6 and UK veterans,7 however, found no increased
risk of death from cancer.
We examined whether UK Gulf veterans have experienced
increased incidence rates of cancer in the 11 years since the end
of the war compared with service personnel not deployed;
whether any excess risk, if found, could be explained by the pos-
sible confounding effects of lifestyle factors (such as cigarette
smoking and alcohol consumption); and whether risk of cancer
is related to self reported exposures to potentially hazardous
material during the period of deployment.
Methods
We carried out a cohort study of all UK armed forces personnel
who served in the Gulf area sometime between September 1990
and June 1991 (the “Gulf” cohort). Specific details of the “Gulf
area” as defined for this study have previously been described.7 A
comparison group of the same size was randomly selected from
members of the armed forces who were in service on 1 January
1991 but who were not deployed to the Gulf area (the “Era”
cohort). This comparison group was stratified to match the Gulf
cohort on age, sex, service branch and rank, and (for the army
and air force) level of fitness for active service. Staff from the Gulf
Veterans’ Illnesses Unit of the Ministry of Defence identified Gulf
cohort members and selected Era cohort members.
Details of all members of the two cohorts were sent to
National Statistics for identification on the NHS central register.
This register was established in 1939 and contains an entry for
everyone in the United Kingdom who has ever been registered
with a general practitioner and all people born in, or who have
immigrated to, the United Kingdom. The register contains infor-
mation on cancers diagnosed, including date of diagnosis and
information on site of cancer, coded according to ICD-10 (inter-
national classification of diseases, 10th revision). Information is
also available (with dates) on deaths and on people emigrating
from the United Kingdom.
Over 96% of members of both cohorts were identified and
“flagged” on the NHS central register and are included in the
current analysis. We included information on the first diagnoses
of malignant cancer (ICD-10 codes C00-C95) registered on the
NHS central register with date of diagnosis before 31 July 2002.
We calculated person years at risk for cancer from 1 April 1991
(the nominal end of the Gulf War) until the earliest of either date
of emigration from the United Kingdom, date of death, date of
first diagnosis of cancer, or 31 July 2002.
We analysed the data with a Cox proportional hazards model
with adjustment for sex, age group, service branch and rank, and
a comparison between Gulf and Era veterans, that is, expressed
as an incidence rate ratio (equivalent to the hazard ratio) with
95% confidence interval. To determine whether the incidence
rate ratio changed with time, it was calculated separately for the
periods before (inclusive) and after December 1997 (this date
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was chosen to give the same number of incident cancers in the
two time periods).
The Gulf and Era cohorts also acted as a sampling frame for
three morbidity surveys conducted between 1997-2001.1 2 8 The
first two surveys, both surveys of general health, drew random
samples from each of the cohorts (using non-overlapping
samples) while the third survey, a study of reproductive and child
health, included all people in both cohorts (table 1). These stud-
ies collected information in a consistent way about tobacco
smoking (current smoker, previous smoker, never smoker), alco-
hol intake at the time of the survey, and, in the Gulf cohort, expo-
sures to potentially hazardous material during service in the
Gulf. We used information from the third study if possible
(n = 40 853) and otherwise from studies 1 and 2 (n = 8494).
Among people participating in at least one of these three
morbidity surveys, we compared the incidence of cancer between
Gulf and Era cohort members, additionally adjusting for the
effects of tobacco smoking and alcohol intake using a Cox pro-
portional hazards model. Secondly, we compared cancer
incidence according to certain exposures during the time in the
Gulf. Effects are again reported as incidence rate ratios and 95%
confidence intervals.
Results
Both cohorts initially comprised 53 462 members. We excluded
from follow up 44 from the Gulf cohort and 10 from the Era
cohort who had died, two from each cohort who had emigrated,
29 from the Gulf cohort and 52 from the Era cohort who had
had cancer diagnosed before 1 April 1991, and five in each
cohort who were recorded as having had cancer diagnosed but
without a date. A further 3987 people (1653 Gulf and 2334 Era)
could not be identified on the NHS central register. Further
information from the Ministry of Defence resulted in the exclu-
Table 1 Morbidity surveys among Gulf War veterans and service personnel who were not deployed in the Gulf (Era cohort)
Survey Reference Date of survey
No of participants
Gulf Era cohort
1 Unwin, 19991 Sept 1997 - Nov 1998 2 735 2 422
2 Cherry, 20012 Dec 1997 - Sep 1999 8 081 3 935
3 Maconochie, 20038 Aug 1998 - Mar 2001 25 084 19 003
Table 2 Demographic and military characteristics of cohort members eligible for follow up according to whether they served in the Gulf. Figures are
numbers (percentages) of members
Gulf cohort (n=51 721) Era cohort (n=50 755) Total
Men 50 637 (98) 49 685 (98) 100 322 (98)
Women 1 084 (2) 1 070 (2) 2 154 (2)
Age (years):
<20 6 165 (12) 6 038 (12) 12 203 (12)
20-24 18 390 (35) 17 880 (35) 36 270 (35)
25-29 12 463 (24) 12 287 (24) 24 750 (24)
30-34 7 648 (15) 7 569 (15) 15 217 (15)
35-39 4 197 (8) 4 173 (8) 8 370 (8)
>39 2 858 (6) 2 808 (6) 5 666 (6)
Rank:
Officer 5 779 (11) 5 626 (11) 11 405 (11)
Other ranks 45 942 (89) 45 129 (89) 91 071 (89)
Service branch:
Army 36 272 (70) 35 324 (70) 71 596 (70)
Navy 5 738 (11) 5 706 (11) 11 444 (11)
Air Force 9 711 (19) 9 725 (19) 19 436 (19)
Table 3 Occurrence of cancer among cohort members according to whether they served in the Gulf: demographic and military characteristics
Gulf cohort (n=51 721) Era cohort (n=50 755) Incidence rate ratio (95% CI)
All cancers 270 269 0.99 (0.83 to 1.17)
Men 257 256 0.99 (0.83 to 1.17)
Women 13 13 0.98 (0.47 to 2.12)
Age (years):
<20 11 12 0.90 (0.40 to 2.03)
20-24 39 48 0.79 (0.52 to 1.21)
25-29 46 41 1.11 (0.73 to 1.69)
30-34 41 40 1.02 (0.66 to 1.57)
35-39 52 38 1.37 (0.90 to 2.08)
>39 81 90 0.89 (0.66 to 1.20)
Rank:
Officer 77 64 1.18 (0.84 to 1.64)
Other ranks 193 205 0.93 (0.76 to 1.13)
Service branch:
Army 170 175 0.95 (0.77 to 1.17)
Navy 38 26 1.46 (0.88 to 2.40)
Air Force 62 68 0.92 (0.65 to 1.29)
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sion of eight from the Gulf cohort and 304 from the Era cohort
who did not meet the entry criteria. Table 2 gives the
demographic characteristics of the 51721 and 50755 cohort
members who were followed up.
During follow up cancer was diagnosed in 270 Gulf veterans
and 269 Era veterans (incidence rate ratio 0.99, 95% confidence
interval 0.83 to 1.17) (table 3). There was no large or significant
excess of cancers in either men or women or in any service
branch, rank, or age group. The incidence rate ratio did not differ
significantly between the period up to and including 1997 (1.04,
0.82 to 1.32) and the later period (0.93, 0.74 to 1.19). After exclu-
sion of non-melanoma skin cancers and cancers for which site
information was unavailable, there were a total of 213 and 215
Gulf and Era veterans, respectively, in whom cancer was
diagnosed (0.97, 0.81 to 1.18) (table 4).
A comparison of incidence rates of cancer among subgroups
of cohort members who participated in one of the morbidity
surveys and provided information on smoking and alcohol simi-
larly showed no significant excess of cancers among the Gulf
veterans (1.11, 0.86 to 1.44). This incidence rate ratio was slightly,
but not significantly, higher than that among cohort members
who did not take part in one of the morbidity surveys (0.95, 0.75
to 1.19). Among cohort members who did participate in a mor-
bidity survey, the incidence rate ratio did not change (1.12, 0.86
to 1.45) after we adjusted for smoking status (current, past, never
smoker) and for the usual intake of alcohol at the time they com-
pleted the questionnaire (table 5). This additional adjustment for
tobacco and alcohol intake also resulted in little or no change in
any of the risks for site specific cancers (table 5). Finally, among
the Gulf veterans who participated in at least one of the morbid-
ity surveys we examined the incidence of cancer with respect to
some of the exposures reported during deployment to the Gulf.
Neither exposure to pesticides (through handling, personal use,
or sprayed accommodation) nor multiple vaccination against
anthrax, plague, and pertussis nor reported exposure to depleted
uranium was associated with any subsequent significant excess
risk of cancer, either overall (table 6) or for site specific cancers
(data not shown).
Discussion
Our study of 102 476 veterans has shown that the incidence of
cancer in those who served in the Gulf was similar to that in veter-
ans who were fit for active service but were not deployed. This
Table 4 Occurrence of site specific cancer among cohort members according to whether they served in the Gulf
Cancer type (ICD-10 code) Gulf Era Incidence rate ratio
All cancers C00-97 268 265 0.98 (0.82 to 1.18)
All excluding non-melanoma skin cancer All except C44 213 215 0.97 (0.81 to 1.18)
Oral cavity C00-14 9 8 1.11 (0.43 to 2.87)
Upper digestive tract C15-17 9 6 1.47 (0.53 to 4.14)
Lower digestive tract C18-21 13 18 0.71 (0.35 to 1.45)
Bronchus, lung, and trachea C33-34 14 18 0.76 (0.38 to 1.54)
Malignant melanoma skin C43 14 10 1.38 (0.61 to 3.10)
Other skin C44 55 50 1.08 (0.74 to 1.59)
Breast C50 6 10 0.59 (0.21 to 1.62)
Prostate C61 7 6 1.15 (0.39 to 3.41)
Testis C62 39 46 0.83 (0.54 to 1.28)
Urinary tract C64-8 13 9 1.42 (0.61 to 3.32)
Central nervous system C69-72 21 25 0.83 (0.46 to 1.48)
Lymphoid and haematopoietic C81-96 45 34 1.30 (0.83 to 2.03)
All other sites Various* 23 25 0.90 (0.51 to 1.59)
ICD code unavailable 2 4
*C22-32, 35-42, 45-49, 51-60, 63, 73-80, 97.
Table 5 Occurrence of site specific cancer among cohort members according to whether they served in the Gulf: adjusted for smoking and alcohol
consumption
Cancer type ICD-10 code Gulf (n=28 518) Era (n=20 829)
Incidence rate ratio
Unadjusted Adjusted
All cancers C00-97 144 95 1.11 (0.86 to 1.44) 1.12 (0.86 to 1.45)
All excluding non-melanoma skin
cancer
All except C44 109 75 1.06 (0.79 to 1.43) 1.07 (0.79 to 1.43)
Oral cavity C00-14 4 5 0.59 (0.16 to 2.18) 0.58 (0.16 to 2.16)
Upper digestive tract C15-17 2 2 0.73 (0.10 to 5.19) 0.69 (0.10 to 4.93)
Lower digestive tract C18-21 6 6 0.73 (0.24 to 2.27) 0.73 (0.24 to 2.27)
Bronchus, lung, and trachea C33-34 3 5 0.49 (0.10 to 1.84) 0.41 (0.10 to 1.73)
Malignant melanoma skin C43 10 5 1.46 (0.50 to 4.28) 1.50 (0.51 to 4.40)
Other skin C44 35 20 1.28 (0.74 to 2.22) 1.30 (0.75 to 2.26)
Breast C50 5 4 0.91 (0.25 to 3.41) 0.98 (0.26 to 3.64)
Prostate C61 4 3 0.98 (0.22 to 4.36) 1.03 (0.23 to 4.62)
Testis C62 24 15 1.17 (0.61 to 2.23) 1.17 (0.61 to 2.23)
Urinary tract C64-8 7 4 1.28 (0.37 to 4.37) 1.29 (0.38 to 4.41)
Central nervous system C69-72 12 8 1.10 (0.45 to 2.68) 1.08 (0.44 to 2.65)
Lymphoid and haematopoietic C81-96 24 11 1.60 (0.78 to 3.26) 1.60 (0.79 to 3.28)
All other sites Various* 8 7 0.84 (0.30 to 2.31) 0.84 (0.30 to 2.32)
ICD code unavailable 2 0
*C22-32, 35-42, 45-49, 51-60, 63, 73-80, 97.
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result did not change when we took into account the effects of life-
style (smoking and alcohol consumption) among a subgroup who
participated in one of the UK morbidity surveys. In this subgroup
there was no significant excess risk of cancer associated with
reported exposure to pesticides, multiple vaccination against
anthrax, plague and pertussis, or exposure to depleted uranium.
There are several methodological considerations regarding
the current study. Firstly, though we excluded the small number
of cohort members who could not be traced through the NHS
central register, some information was available on diagnoses of
cancer in these people from alternative sources. Among them
the number of cancers was higher in the Era cohort (n = 11) than
in the Gulf cohort (n = 3). Secondly, information on lifestyle hab-
its was obtained only at the time of the morbidity surveys, 6-10
years after the Gulf war. These data show that the proportion
who were current smokers and the amount of alcohol drunk in a
week were similar in the two cohorts,1 2 and thus the estimates of
rate ratios are little changed with adjustment for these factors.
We will have underestimated the relative risk of cancer in Gulf
war veterans only if they habitually smoked less or drank less
alcohol and had recently increased consumption (or vice versa in
relation to Era veterans). Neither seems plausible. Finally, the
“exposures” reported at the time of the Gulf are, in the absence
of any objective measure of individual exposure, based on self
report. The concern about self reported exposures is that people
who develop an adverse health outcome may differentially recall
past events. This is most likely to result in ill people
over-reporting past exposures and well people under-reporting
(that is, forgetting) them. With either scenario, the observed
effect of an exposure on health will be overestimated and there-
fore this could not explain our failure to detect true adverse
effects of any of these exposures if they were to exist.
Relatively little information has been published on cancers
among Gulf war veterans. The mortality study among the same
group of UK Gulf and Era veterans showed only a small
non-significant increased risk of death from cancer nine years
after the end of the conflict (mortality rate ratio 1.11, 0.73 to
1.67).7 A mortality study among US veterans also failed to show
an increased risk of death from cancer seven years after the end
of the conflict (0.90, 0.81 to 1.01, for men; 1.11, 0.78 to 1.57 for
women).6 In the US study there was no increased risk of death
from cancer among Gulf War veterans who were potentially
exposed to nerve gas as a result of US troops exploding
abandoned Iraqi munitions (0.95, 0.69 to 1.30). An early report
of an increased risk of testicular cancer in the period
immediately after deployment was no longer evident on further
follow up. It was concluded that the original observed excess was
because healthy serviceman were selected for deployment and
care was deferred during deployment.5
In summary, our results confirm that there is no overall
increase in incidence of or mortality from cancer among UK
Gulf veterans. Neither was the incidence of cancer higher among
those veterans who reported specific exposures during their
deployment. Although this study should provide some
reassurance of a lack of association between deployment to the
Gulf and increased risk of cancer, the long latent period for
cancer requires that these cohorts should continue to be
followed up and their experience of cancer monitored.
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